User login
In a study of 1816 patients with tuberous sclerosis complex (TSC), researchers found that specific disease manifestations—cardiac rhabodmyomas, retinal hemartomas, renal cysts, renal angiomyolipipomas, and facial angiofibromas—were associated with a higher likelihood of epilepsy development. The authors posit that this research can help identify patients who will benefit from novel, targeted, preventative treatments.
Jeong A, Wong M. Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex [published online ahead of print July 15, 2016]. Epilepsia. 2016;doi:10.1111/epi.13467.
In a study of 1816 patients with tuberous sclerosis complex (TSC), researchers found that specific disease manifestations—cardiac rhabodmyomas, retinal hemartomas, renal cysts, renal angiomyolipipomas, and facial angiofibromas—were associated with a higher likelihood of epilepsy development. The authors posit that this research can help identify patients who will benefit from novel, targeted, preventative treatments.
Jeong A, Wong M. Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex [published online ahead of print July 15, 2016]. Epilepsia. 2016;doi:10.1111/epi.13467.
In a study of 1816 patients with tuberous sclerosis complex (TSC), researchers found that specific disease manifestations—cardiac rhabodmyomas, retinal hemartomas, renal cysts, renal angiomyolipipomas, and facial angiofibromas—were associated with a higher likelihood of epilepsy development. The authors posit that this research can help identify patients who will benefit from novel, targeted, preventative treatments.
Jeong A, Wong M. Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex [published online ahead of print July 15, 2016]. Epilepsia. 2016;doi:10.1111/epi.13467.